Cargando…
Cholinesterase inhibitors for gait, balance, and fall in Parkinson disease: a meta-analysis
Gait disturbance and imbalance are the major symptoms of Parkinson disease (PD), with fall being the most undesirable consequence. However, few effective evidence-based treatments are available for alleviating these symptoms and preventing falls. Cholinesterase inhibitors (ChEIs) are a well-establis...
Autores principales: | Chen, Jia-Hung, Huang, Tsai-Wei, Hong, Chien-Tai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617004/ https://www.ncbi.nlm.nih.gov/pubmed/34824258 http://dx.doi.org/10.1038/s41531-021-00251-1 |
Ejemplares similares
-
Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials
por: Hong, Chien-Tai, et al.
Publicado: (2022) -
Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis
por: Meng, Yan-Hong, et al.
Publicado: (2019) -
Should One Measure Balance or Gait to Best Predict Falls among People with Parkinson Disease?
por: Duncan, Ryan P., et al.
Publicado: (2012) -
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
por: Neumann, S., et al.
Publicado: (2021) -
Use of antipsychotic drugs and cholinesterase inhibitors and risk of falls and fractures: self-controlled case series
por: Wang, Grace Hsin-Min, et al.
Publicado: (2021)